載脂蛋白C1(APOC1)多克隆抗體
Polyclonal Antibody to Apolipoprotein C1 (APOC1)
Apo-C1; Truncated apolipoprotein C-I
- 編號PAA252Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA252Hu01-載脂蛋白C1(APOC1)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Mus musculus (Mouse，小鼠)
- 應(yīng)用WB; IHC; ICC/IF; FCM
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 569 ¥ 1327 ¥ 1896 ¥ 4740 ¥ 18960
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Liver Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human APOC1 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;<br/>Sample: Mouse Liver Tissue; <br/>Primary Ab: 20μg/ml Rabbit Anti-Human APOC1 Antibody<br/>Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19)
-
FITC staining on IF;
Sample: Hela cell
Primary Ab: 30μg/ml Rabbit Anti-Human APOC1 Antibody
Second Ab: 2μg/ml FITC-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb11) -
FITC staining on IF;
Sample: Human Hela cell;
Primary Ab: 30ug/ml Rabbit Anti-Human APOC1 Antibody
Second Ab: 2μg/ml FITC-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb18)
-
Figure. Western Blot; Sample: Recombinant APOC1, Human.
-
Western Blot; Sample: Lane1: Human Serum; Lane2: Human Placenta lysate; Lane3: Mouse Liver lysate<br/>Primary Ab: 0.2μg/ml Rabbit Anti-Human APOC1 Antibody<br/>Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19) Selected
-
Western Blot; Samples: Lane1: HepG2 treated with BFA for 24 hours, cell supernatant; Lane2: Untreated HepG2 cell lysate;
Primary Ab: 0.1μg/ml Rabbit Anti-Human APOC1 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Human HepG2 cell was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20μg/ml rabbit Anti-human APOC1 Polyclonal Antibody (Catalog PAA252Hu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1μg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對APOC1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別APOC1。
用法
Western blotting: 0.01-3μg/mL;
Immunohistochemistry: 5-30μg/mL;
Immunocytochemistry: 5-30μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA252Hu01 | 載脂蛋白C1(APOC1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA252Hu01 | 載脂蛋白C1(APOC1)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA252Hu02 | 載脂蛋白C1(APOC1)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA252Hu02 | 載脂蛋白C1(APOC1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA252Hu01 | 載脂蛋白C1(APOC1)多克隆抗體 | WB; IHC; ICC/IF; FCM |
| PAA252Hu02 | 載脂蛋白C1(APOC1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA252Hu71 | 載脂蛋白C1(APOC1)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA252Hu21 | 載脂蛋白C1(APOC1)單克隆抗體 | WB |
| MAA252Hu23 | 載脂蛋白C1(APOC1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA252Hu22 | 載脂蛋白C1(APOC1)單克隆抗體 | WB; IHC; ICC; IP. |
| FAA252Hu02 | 抗載脂蛋白C1(APOC1)單克隆抗體 | FCM |
| FAA252Hu04 | 抗載脂蛋白C1(APOC1)單克隆抗體 | Flow cytometry. |
| SEA252Hu | 載脂蛋白C1(APOC1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA252Hu | 載脂蛋白C1(APOC1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| CGA252Hu02 | 載脂蛋白C1(APOC1)cDNA | PCR、蛋白表達等 |
參考文獻
| 雜志 | 參考文獻 |
| PROTEOMICS - Clinical Applications | Proteomic and genomic analyses suggest the association of Apolipoprotein C1 with abdominal aortic aneurysm [Onlinelibrary: prca.201300119] |
| Journal of Dairy Science | Colostrum and milk protein rankings and ratios of importance to neonatal calf health using a proteomics approach [pubmed:28189329] |
| RESPIRATORY RESEARCH | The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation?… [Pubmed: 33148285] |
留言咨詢
